Breast cancer prediction report. Without effective interventions, many countries will fall short of the WHO Global Breast Cancer Initiative's ambitious target of Breast Cancer Diagnosis Prediction with Python: Decision Tree vs Random Forest Project Overview This project uses the Breast Cancer Wisconsin dataset to predict whether a tumor is benign or malignant using machine learning. Breast Cancer Drug ADMET Solubility Prediction using Machine Learning This repository contains machine learning models developed to predict the aqueous solubility (ESOL Log S) of potential breast cancer drug candidates using ADMET descriptors. 49% accuracy using Random Forest. Machine learning has the potential to predict breast cancer based on features hidden in data. Breast cancer is considered one of the most common cancers in women caused by various clinical, lifestyle, social, and economic factors. I compared a Decision Tree and a Random Forest model, with a strong focus on identifying malignant cases accurately. An AI-powered breast cancer detection web application built with Flask and Random Forest classification, trained on the Wisconsin Breast Cancer Dataset. We would like to show you a description here but the site won’t allow us. This systematic review summarizes all developed models for BC risk in general and high-risk populations, and their discriminatory ability and calibration. Predicts Malignant or Benign tumors with 96. AI-powered breast cancer classification web app trained on the Wisconsin Breast Cancer Dataset. The stable incidence and declining mortality rates of female breast cancer in high-income nations reflect success in screening, diagnosis, and treatment. Data preprocessing, feature scaling, and train–test split are applied. In contrast, the concurrent rise in incidence and mortality in other regions signals health system deficits. . The components obtained will be sent to the SVM which classifies the cancer based on Multi-Level and helps in prediction of malignancy of cancer, the early dangerous stage will urge clinical 4 days ago · In this Perspective, David Page and colleagues discuss how spatially profiling immune-tumor cell interactions using multispectral immunofluorescence analyses holds promise as a biomarker to predict outcomes in early-stage breast cancer. The tool uses a woman's personal medical and reproductive history and the history of breast cancer among her first-degree relatives (mother, sisters, daughters) to estimate absolute breast cancer risk—her chance or probability of developing invasive breast cancer in a defined age interval. Explainable AI system for breast cancer diagnosis using Random Forest, SHAP, and LIME with a FastAPI backend and Next. Lyon, France, 24 February 2025 – A new analysis by the International Agency for Research on Cancer (IARC) and collaborators evaluates the latest and future burden of female breast cancer globally, with a detailed analysis in about 50 countries with high-quality population-level cancer data. js frontend. 2 days ago · A new study highlights how Personalis’ NeXT Personal assay outperformed standard methods in predicting breast cancer relapse after neoadjuvant therapy, accurately identifying high- and low-risk patients using ultrasensitive ctDNA detection. 1 day ago · Wells Fargo raised its Merck price target to $150, betting that sac-TMT’s potential to displace chemotherapy across multiple cancer indications, combined with KEYTRUDA’s continued growth and a Includes multiple regression algorithms, trained models, and performance comparison. About the Report: The report provides a comprehensive analysis of the global breast cancer prediction tools market from 2025 to 2035. - hanaa12334/breast-cancer-prediction-xai Contribute to mouhamed-diakhate/breast-cancer-detection-api development by creating an account on GitHub. Predict is an online tool that helps patients and clinicians see how different treatments for early invasive breast cancer might improve survival rates after surgery. This study aimed 4 days ago · Have questions about what your ctDNA or MRD results mean for your breast cancer care? Learn more about how these blood tests work, when they’re typically ordered, and how they can help your care team detect tiny amounts of remaining cancer and tailor your follow up and treatment choices. It is endorsed by the American Joint Committee on Cancer (AJCC). Logistic Regression and Decision Tree classify tumors as benign or malignant and are evaluated using accuracy, precision, recall, F1-score, and confusion matrix. BREAST-CANCER-PREDICTION A machine learning–based system for early breast cancer detection using the Breast Cancer Wisconsin dataset. Oct 29, 2025 · We present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel DL approach that integrates traditional risk factors and longitudinal mammography data to capture subtle tissue Oct 27, 2025 · Existing BC risk prediction models typically utilize demographic, genetic, and/or imaging-derived variables. This review aims to synthesize recent advancements in AI-based breast cancer risk prediction, evaluate their contribution to the field, and explore both their limitation and application in clinical practice. bmnsxn vhcq sxpa xnsejwp swvop qtth rbjf rncmt ameso yjxn